Literature DB >> 7016212

Cisplatin: chemistry, distribution and biotransformation.

D F Long, A J Repta.   

Abstract

A review of the use of cisplatin in cancer chemotherapy in humans is presented. The emphasis is placed on the chemistry, in vivo distribution and biotransformation of this agent. The existing literature pertinent to the physicochemical properties of cisplatin and structure activity relationships of platinum coordination complexes is reviewed. The chemistry of this drug, both in aqueous media and in biological systems is discussed as well as current analytical methodology used for monitoring 'cisplatin levels' in biological fluids. Recent advances in analytical methodology specific for cisplatin are also presented and recent findings in the area of the possible biotransformations of this important anticancer agent are discussed.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7016212     DOI: 10.1002/bdd.2510020102

Source DB:  PubMed          Journal:  Biopharm Drug Dispos        ISSN: 0142-2782            Impact factor:   1.627


  14 in total

1.  Application of prolonged microdialysis sampling in carboplatin-treated cancer patients.

Authors:  Inge R H M Konings; Frederike K Engels; Stefan Sleijfer; Jaap Verweij; Erik A C Wiemer; Walter J Loos
Journal:  Cancer Chemother Pharmacol       Date:  2008-12-20       Impact factor: 3.333

2.  C-phycocyanin prevents cisplatin-induced mitochondrial dysfunction and oxidative stress.

Authors:  Berenice Fernández-Rojas; Daniela Sarai Rodríguez-Rangel; Luis Fernando Granados-Castro; Mario Negrette-Guzmán; Juan Carlos León-Contreras; Rogelio Hernández-Pando; Eduardo Molina-Jijón; José L Reyes; Cecilia Zazueta; José Pedraza-Chaverri
Journal:  Mol Cell Biochem       Date:  2015-05-14       Impact factor: 3.396

3.  In vitro interactions of TNO6 with human plasma.

Authors:  B Hecquet; L Adenis; A Demaille
Journal:  Cancer Chemother Pharmacol       Date:  1983       Impact factor: 3.333

Review 4.  Platinum antitumour agents: a review of (bio)analysis.

Authors:  T J Hodes; W J Underberg; G Los; J H Beijnen
Journal:  Pharm Weekbl Sci       Date:  1992-06-19

5.  An imaging-driven model for liposomal stability and circulation.

Authors:  Shengping Qin; Jai Woong Seo; Hua Zhang; Jinyi Qi; Fitz-Roy E Curry; Katherine W Ferrara
Journal:  Mol Pharm       Date:  2010-02-01       Impact factor: 4.939

Review 6.  Pharmacokinetics of anticancer drugs in children.

Authors:  W R Crom; A M Glynn-Barnhart; J H Rodman; M E Teresi; R E Kavanagh; M L Christensen; M V Relling; W E Evans
Journal:  Clin Pharmacokinet       Date:  1987-03       Impact factor: 6.447

7.  Copper-tolfenamic acid: evaluation of stability and anti-cancer activity.

Authors:  Myrna Hurtado; Umesh T Sankpal; Jaya Chhabra; Deondra T Brown; Rajasekhar Maram; Rafid Patel; Raj K Gurung; Jerry Simecka; Alvin A Holder; Riyaz Basha
Journal:  Invest New Drugs       Date:  2018-05-15       Impact factor: 3.850

8.  Development of a Nanoparticle-Embedded Chitosan Sponge for Topical and Local Administration of Chemotherapeutic Agents.

Authors:  Manijeh Goldberg; Aaron Manzi; Erkin Aydin; Gurtej Singh; Payam Khoshkenar; Amritpreet Birdi; Brandon LaPorte; Alejandro Krauskopf; Geralle Powell; Julie Chen; Robert Langer
Journal:  J Nanotechnol Eng Med       Date:  2014-11

9.  Pharmacokinetic and biotransformation studies of ormaplatin in conjunction with a phase I clinical trial.

Authors:  W P Petros; S G Chaney; D C Smith; J Fangmeier; M Sakata; T D Brown; D L Trump
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

10.  Formation and stability of interstrand cross-links induced by cis- and trans-diamminedichloroplatinum (II) in the DNA of Saccharomyces cerevisiae strains differing in repair capacity.

Authors:  F Wilborn; M Brendel
Journal:  Curr Genet       Date:  1989-12       Impact factor: 3.886

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.